Navigation Links
Electrocardiograms plays a limited role

A recent report indicates that Negative exercise electrocardiograph tests should be the first-line approach to risk stratification of hypertensive patients with chest pain. Even though negative findings identified those at low risk, positive findings could not distinguish levels of risk. The research also indicated that pharmacological stress echocardiography yielded diagnostic and prognostic information with stronger predictive power than clinical or exercise electrocardiography.// They compared the value of clinical data, exercise electrocardiography and pharmacological stress echocardiography in a sample total of hypertensive men and women aged around 60, who had chest pain. They were subjected to electrocardiography and pharmacological stress echocardiography. The result showed that, predictor of either death or hard events (death, myocardial infarction) was a positive stress echocardiography provided more predictive information on clinical evaluation. But in assessing four-year event-free echocardiography. On further analysis, stress survival, the negative predictive value of the two tests was similarly high.
'"/>




Page: 1

Related medicine news :

1. Diet plays a role in kidney stones
2. Treadmill test displays hidden heart disease
3. Clotting Protein plays a role in nerve repair
4. Lifestyle plays an important role in determining one’s ag
5. Depression plays a vital role in Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: